Sep 19, 2023 8:00am EDT bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
Sep 07, 2023 8:00am EDT bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
Aug 14, 2023 5:03pm EDT bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
Jul 12, 2023 8:00am EDT AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
Jun 15, 2023 8:00am EDT bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
